Novel Therapeutic Approaches in the Treatment of Multiple Myeloma

Last Modified: April 6, 2005

Conference Dates: June 9-10, 2005
Conference Location: Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, WA

Sponsoring Group: University of Washington School of Medicine and the Multiple Myeloma Research Foundation

Conference Web Page URL:

Conference Objectives:

  1. Indentify the prognostic indicators and diagnostic approaches to multiple myeloma.
  2. Discuss the latest advances in stem cell transplantation, treatments for bone disease, and supportive care management.
  3. Describe the role and appropriate use of novel treatments for multiple myeloma throughout the disease progression.

Who Should Attend: June 9: Patients; June 10: Hematologists, Medical Oncologists, Oncology Nurses, Internists with Newly Diagnosed Patients

Registration Information: Contact the MMRF at 203-972-1250 or visit

Conference Fees: Patient Program: Free; Professional Program: $35 Registration Fee

Continuing Education: Yes. 3 Category 1 credits available for physicians


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

ASH: Novel Drug Beneficial in Multiple Myeloma

Nov 30, 2015

Second-generation proteasome inhibitor linked to response rate of 45 percent, few side effects

Stem-Cell Transplant Key to Early Multiple Myeloma Therapy

Nov 30, 2015

Autologous hematopoietic stem-cell transplantation should be part of initial treatment

Continuous Therapy Improves Survival in Multiple Myeloma

Aug 31, 2015

Benefit seen in progression-free, overall survival compared with fixed duration of therapy